A carregar...
A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab
First-line chemotherapy regimens that include bevacizumab (Bev) have been hypothesized to improve outcomes in patients with advanced non-squamous non-small cell lung cancer (non-sq NSCLC). Although approved to treat NSCLC in 2009, insufficient data exist on the clinical uses of Bev in Japan. The pre...
Na minha lista:
Publicado no: | Oncol Lett |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
D.A. Spandidos
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5431393/ https://ncbi.nlm.nih.gov/pubmed/28521435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5796 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|